Sypharma Pty Ltd
Best Biopharmaceutical Formulations Manufacturer & Supplier – Australia & Most Forward-Thinking Pharmaceutical CEO (Asia Pacific): Elaine Chan
Elaine Chan is the CEO of Sypharma, an Australian specialist contract manufacturing group and trusted provider of biotechnology healthcare products. Over the past five years, Elaine has leads the organisation through an enormous growth stage, doubling the size and production capabilities of the Australian based facility. In 2020 Sypharma partnered with the University of Queensland’s on their Rapid Response Vaccine Pipeline Program, managing the fill and finish of their SARS-CoV-2 Sclamp Vaccine for Phase 1 clinical trials. Elaine is proud to contribute to the creation of products in support of healthier futures for our communities.